# Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

> **NCT00003646** · PHASE2 · COMPLETED · sponsor: **Vical** · enrollment: 78 (actual)

## Conditions studied

- Stage IV Melanoma
- Stage III Melanoma
- Recurrent Melanoma

## Interventions

- **DRUG:** allovectin-7

## Key facts

- **NCT ID:** NCT00003646
- **Lead sponsor:** Vical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-08
- **Primary completion:** 2002-03
- **Final completion:** 2002-05
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2011-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003646, "Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00003646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*